bf/NASDAQ:GTBP_icon.jpeg

NASDAQ:GTBP

GT Biopharma, Inc.

  • Stock

USD

Last Close

2.72

26/07 20:00

Market Cap

6.06M

Beta: 0.86

Volume Today

2.40K

Avg: 131.26K

PE Ratio

−15.25

PFCF: −19.13

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
2.50
-
0.07
97.26%
0.50
627.87%
cash conversion cycle
-1.41K
-
-2.64K
87.03%
cash per share
95.77
-
1.84K
1,824.09%
100
94.57%
3.97
96.03%
0.58
85.28%
0.02
96.52%
0.01
59.26%
1.21
14,504.29%
1.14
5.97%
0.52
54.39%
10.37
1,901.33%
company equity multiplier
-0.02
-
-0.03
26.98%
-0.00
97.10%
-0.00
52.22%
1.01
75,867.64%
2.20
117.94%
-0.02
100.94%
-0.19
835.04%
1.47
858.99%
1.43
2.86%
1.89
32.32%
days of inventory outstanding
67.83
-
days of payables outstanding
1.52K
-
2.64K
73.78%
days of sales outstanding
39.67
-
dividend yield
ebit per revenue
-2.15
-
-39.28
1,722.77%
-330.63
741.75%
ebt per ebit
0.71
-
9.80
1,278.39%
3.67
62.61%
-2.24
161.21%
1.06
147.09%
1.04
1.91%
2.41
132.23%
4.18
73.80%
1.01
75.89%
0.98
2.60%
0.56
43.04%
effective tax rate
0.52
-
-0.22
142.32%
-0.52
137.65%
-1.45
177.67%
-0.05
96.29%
0.88
1,745.12%
-0.06
106.25%
-0.12
113.09%
-0.01
90.01%
0.02
255.64%
enterprise value multiple
-1.17
-
-1.08
8.07%
-1.09
1.58%
-0.28
74.52%
-0.54
94.95%
-2.01
271.13%
-1.57
21.96%
-2.72
73.02%
-1.34
50.78%
-1.08
18.98%
-0.68
36.91%
fixed asset turnover
10.17
-
5.40
46.89%
free cash flow per share
-984.41
-
-3.78K
284.22%
-9.91K
162.02%
-402.84
95.94%
-5.51
98.63%
-3.62
34.20%
-1.08
70.18%
-1.66
53.22%
-0.55
66.53%
-0.48
13.85%
-6.57
1,275.52%
gross profit margin
0.39
-
0.07
83.01%
1
1,425%
interest coverage
0.66
-
-0.47
170.22%
-0.52
12.52%
1.43
372.95%
15.76
1,002.08%
-27.43
274.04%
-7.55
72.49%
-2.04
73.00%
-80.10
3,831.80%
-2.66K
3,217.08%
-63.74
97.60%
inventory turnover
5.38
-
long term debt to capitalization
-0.02
-
-0.02
38.21%
-0.01
46.84%
0.01
-
net income per ebt
0.89
-
1
12.57%
1
0%
1
0%
1
0%
1
0%
1.06
5.51%
1.12
5.90%
1.01
9.45%
0.98
2.96%
1
1.86%
net profit margin
-1.36
-
-385.07
28,184.26%
-1.21K
214.77%
operating cash flow per share
-984.41
-
-3.77K
282.91%
-9.91K
162.87%
-402.84
95.93%
-5.50
98.63%
-3.61
34.37%
-1.08
70.08%
-1.66
53.22%
-0.55
66.53%
-0.48
13.85%
-6.57
1,275.52%
operating cycle
107.51
-
operating profit margin
-2.15
-
-39.28
1,722.77%
-330.63
741.75%
payables turnover
0.24
-
0.14
42.46%
pretax profit margin
-1.53
-
-385.07
25,024.85%
-1.21K
214.77%
price fair value
-0.01
-
-0.00
78.28%
-0.00
51.70%
-0.03
3,251.58%
0.30
1,200.44%
2.83
855.18%
-0.24
108.62%
-1.08
342.67%
3.92
462.77%
2.41
38.61%
1.38
42.69%
receivables turnover
9.20
-
return on assets
-3.41
-
-26.45
676.12%
-606.04
2,191.12%
841.32
238.82%
-0.56
100.07%
-10.20
1,712.06%
-102.97
909.03%
-5.58
94.58%
-1.82
67.33%
-1.23
32.85%
-0.54
56.05%
return on capital employed
0.13
-
0.08
34.88%
0.15
76.41%
0.50
239.15%
-0.54
208.74%
-21.99
3,983.19%
0.83
103.78%
0.23
72.36%
-2.63
1,242.27%
-1.80
31.36%
-1.82
0.79%
return on equity
0.08
-
0.80
885.52%
0.53
33.56%
-1.12
311.31%
-0.57
49.28%
-22.46
3,849.24%
2.13
109.48%
1.08
49.28%
-2.68
347.95%
-1.75
34.77%
-1.02
41.84%
total debt to capitalization
-0.72
-
-0.13
82.10%
-0.19
45.57%
-1.96
942.55%
0.00
100.01%
0.48
392,807.75%
-2.31
577.69%
-8.99
289.10%
0.00
100.02%
0.01
934.20%
0.01
47.31%

All numbers in USD (except ratios and percentages)